WALL STREET JOURNAL - Latest News - Federal Appeals Court Agrees To Rehear Case On Whether People Should Have Access To Experimental Medications
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21). [click link for full article]
Report: Nortel CEO unveils cost-cutting plan
Nortel Networks plans to reduce material costs, research and development spending and administrative costs in an effort to return to profitability, CEO Mike Zafirovski told The Wall Street Journal.
IDS Informed Media Campaign in Wall Street Journal Begins November 29, 2006
IDS Worldwide, Inc. HLS has informed IDS that it will begin a multi-media campaign featuring the world's 1st Vista(TM) compatible biometric encryption flash drives and computer mouse beginning with the Wall Street Journal this Wednesday the 29th of November, one day before Microsoft(TM) releases its new Vista(TM) operating system to government and business customers, HLS and its worldwide
'Peanut butter' memo reveals sticky situation at Yahoo
Industry observers nodded in agreement last week at the conclusions of a scathing internal assessment that has come to be called the "peanut butter" memo.
Accidental delivery and other e-mail traps
"Whoops..."
U.S. Stock-Index Futures Drop After Wal-Mart's Sales Decline
Nov. 27 (Bloomberg) -- U.S. stock-index futures fell after Wal-Mart Stores Inc., the world's biggest retailer, said monthly U.S. same-store sales dropped for the first time in more than a decade.
Jeff Madrick: Is Income Equality Bad for Economic Growth? No
A brief complaint this Thanksgiving. 'No thanks' to the media who parrot the neoclassical line that to do well for workers means you do poorly by the economy. This week, both the Wall Street Journal and The New York Times ran stories wondering whether more equal wages would undermine economic growth. The agenda of the newly Democratic Congress raises fears among some of the economic
Pfizer Tries to Sell Research Spending
November 27, 2006 | The pharmaceutical giant consistently spends the most of any company to find new drugs -- more than $7 billion a year since 2003. Some optimists assert the company's market valuation doesn't adequately reflect the promise of gems hidden inside its labs.
ACS CEO, CFO leaving company after options probe
Affiliated Computer Services Inc. said on Monday its chief executive and chief financial officer had resigned because of their role in improper stock option grant practices.

0 Comments:
Post a Comment
<< Home